LOGIN  |  REGISTER
Viking Therapeutics

Recent Insider Transactions

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ ACCD Accolade
Eskew Richard / officer: EVP General Counsel
01/03/2025
Sell
$3.41
393
$1K
63,260
NASDAQ AKRO Akero Therapeutics
Young Jonathan / officer: Chief Operating Officer
01/02/2025
Sell
$28.03
10,000
$280K
218,083
NASDAQ ALXO ALX Oncology
Pinto Shelly / officer: Interim CFO
12/30/2024
Sell
$1.58
1,426
$2K
90,123
NASDAQ ALXO ALX Oncology
Pons Jaume / officer: PRESIDENT & CSO
12/30/2024
Sell
$1.58
10,796
$17K
580,714
NASDAQ ANAB AnaptysBio
EcoR1 Capital, LLC / director, 10 percent owner:
01/02/2025
Buy
$12.95
6,646
$86K
7.88M
NASDAQ ANAB AnaptysBio
EcoR1 Capital, LLC / director, 10 percent owner:
12/30/2024
Buy
$12.92
65,184
$842K
7.86M
NASDAQ ANAB AnaptysBio
EcoR1 Capital, LLC / director, 10 percent owner:
12/31/2024
Buy
$12.93
13,268
$172K
7.87M
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
01/02/2025
Sell
$47.21
2,486
$117K
255,448
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
01/02/2025
Sell
$46.42
1,499
$70K
257,934
NASDAQ APGE Apogee Therapeutics
Dambkowski Carl / officer: Chief Medical Officer
01/02/2025
Sell
$47.92
100
$5K
255,348
NASDAQ ACLX Arcellx
Heery Christopher / officer: CHIEF MEDICAL OFFICER
01/03/2025
Sell
$79.55
3,301
$263K
35,517
NASDAQ ACLX Arcellx
Gilson Michelle / officer: CHIEF FINANCIAL OFFICER
01/06/2025
Sell
$77.17
5,102
$394K
28,230
NASDAQ ACLX Arcellx
Gilson Michelle / officer: CHIEF FINANCIAL OFFICER
01/03/2025
Sell
$79.55
5,502
$438K
33,332
NASDAQ ACLX Arcellx
Elghandour Rami / director, officer: SEE REMARKS
01/06/2025
Sell
$77.17
13,776
$1.063M
149,176
NASDAQ ACLX Arcellx
Elghandour Rami / director, officer: SEE REMARKS
01/03/2025
Sell
$79.55
14,857
$1.182M
162,952
NASDAQ ACLX Arcellx
Heery Christopher / officer: CHIEF MEDICAL OFFICER
01/06/2025
Sell
$77.17
3,061
$236K
32,456
NYSE RCUS Arcus Biosciences
Goeltz II Robert C. / officer: Chief Financial Officer
12/31/2024
Sell
$15.00
3,594
$54K
60,138
NASDAQ ARQT Arcutis Biotherapeutics
Burnett Patrick / officer: See Remarks
12/31/2024
Sell
$14.00
1,691
$24K
126,978
NASDAQ ARQT Arcutis Biotherapeutics
Welgus Howard G. / director
01/02/2025
Sell
$14.67
10,000
$147K
151,944
NASDAQ ASMB Assembly Biosciences
Houghton Michael / director
12/30/2024
Buy
$15.61
3,202
$50K
3,202
NASDAQ BCYC Bicycle Therapeutics
Skynner Michael / officer: CHIEF TECHNOLOGY OFFICER
01/02/2025
Sell
$14.09
3,287
$46K
124,658
NASDAQ BCYC Bicycle Therapeutics
Lee Kevin / director, officer: CHIEF EXECUTIVE OFFICER
01/03/2025
Sell
$14.75
3,092
$46K
491,934
NASDAQ BCYC Bicycle Therapeutics
Crockett Nigel / officer: CHIEF BUSINESS OFFICER
01/02/2025
Sell
$14.09
2,583
$36K
51,989
NASDAQ BCYC Bicycle Therapeutics
Arroyo Santiago / officer: CHIEF DEVELOPMENT OFFICER
01/02/2025
Sell
$14.09
4,943
$70K
69,057
NASDAQ BCYC Bicycle Therapeutics
Lee Kevin / director, officer: CHIEF EXECUTIVE OFFICER
01/02/2025
Sell
$14.09
9,038
$127K
495,026
NASDAQ BCYC Bicycle Therapeutics
Young Alethia / officer: Chief Financial Officer
01/02/2025
Sell
$14.09
1,395
$20K
45,605
NASDAQ BCYC Bicycle Therapeutics
Hannay Michael Charles Ferguson / officer: CHIEF PROD & SUPPLY CHAIN OFF
01/03/2025
Sell
$14.75
239
$4K
55,280
NASDAQ BCYC Bicycle Therapeutics
Milnes Alistair / officer: CHIEF OPERATING OFFICER
01/03/2025
Sell
$14.75
936
$14K
99,788
NASDAQ BCYC Bicycle Therapeutics
Thompson Travis Alvin / officer: CHIEF ACCOUNTING OFFICER
01/06/2025
Sell
$15.00
2,686
$40K
32,146
NASDAQ BCYC Bicycle Therapeutics
Hannay Michael Charles Ferguson / officer: CHIEF PROD & SUPPLY CHAIN OFF
01/02/2025
Sell
$14.09
1,879
$26K
55,519
NASDAQ BCYC Bicycle Therapeutics
Milnes Alistair / officer: CHIEF OPERATING OFFICER
01/02/2025
Sell
$14.09
4,578
$65K
100,724
NASDAQ BCYC Bicycle Therapeutics
Thompson Travis Alvin / officer: CHIEF ACCOUNTING OFFICER
01/03/2025
Sell
$14.75
159
$2K
34,832
NASDAQ BCYC Bicycle Therapeutics
Skynner Michael / officer: CHIEF TECHNOLOGY OFFICER
01/03/2025
Sell
$14.75
936
$14K
123,722
NASDAQ BCYC Bicycle Therapeutics
Crockett Nigel / officer: CHIEF BUSINESS OFFICER
01/03/2025
Sell
$14.75
936
$14K
51,053
NASDAQ BCYC Bicycle Therapeutics
Thompson Travis Alvin / officer: CHIEF ACCOUNTING OFFICER
01/02/2025
Sell
$14.09
1,750
$25K
34,991
NYSE BFLY Butterfly Network
Stoica Andrei G / officer: Chief Technology Officer
12/31/2024
Sell
$3.30
1,680
$6K
1.45M
NASDAQ CCLD CareCloud
DALY JOHN N / director
12/31/2024
Sell
$3.87
5,000
$19K
61,750
NASDAQ CERS Cerus
Gregory Dean A. / director
12/13/2024
Buy
$1.70
1,725
$3K
61,725
NASDAQ CDXS Codexis
Opaleye Management Inc. / 10 percent owner
12/30/2024
Buy
$4.70
35,000
$164K
8.58M
NASDAQ CDXS Codexis
Opaleye Management Inc. / 10 percent owner
12/31/2024
Buy
$4.66
10,000
$47K
8.59M
NASDAQ CORT Corcept Therapeutics
Maduck Sean / officer: See Remarks
01/02/2025
Sell
$50.39
20,000
$1.008M
85,318
NASDAQ CORT Corcept Therapeutics
Lyon Joseph Douglas / officer: See Remarks
01/02/2025
Sell
$50.39
5,000
$252K
8,759
NASDAQ DNLI Denali Therapeutics
SATO VICKI L / director
01/02/2025
Sell
$20.91
3,080
$64K
107,976
NASDAQ DNLI Denali Therapeutics
Krognes Steve E. / director
12/31/2024
Sell
$20.25
30,000
$608K
29,096
NASDAQ IRON Disc Medicine
Quisel John D / director, officer: Chief Executive Officer
12/30/2024
Sell
$62.41
1,900
$119K
72,065
NASDAQ IRON Disc Medicine
Quisel John D / director, officer: Chief Executive Officer
12/30/2024
Sell
$61.87
11,112
$687K
73,965
NASDAQ EWTX Edgewise Therapeutics
Russell Alan J / director, officer: Chief Scientific Officer
12/30/2024
Sell
$27.37
100,000
$2.737M
14,863
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/27/2024
Sell
$22.15
3,350
$74K
0
NASDAQ ELVN Enliven Therapeutics
Hohl Benjamin / officer: CHIEF FINANCIAL OFFICER
12/30/2024
Sell
$22.51
900
$20K
0
NASDAQ NVNO enVVeno Medical
Duhay Francis / director
12/31/2024
Buy
$3.07
81,433
$250K
102,344
NASDAQ NVNO enVVeno Medical
Gray Robert / director
12/31/2024
Buy
$2.94
3,500
$10K
11,155
NASDAQ GRTX Galera Therapeutics
CHANG NANCY T / director, 10 percent owner:
12/30/2024
Buy
$0.07
7.64M
$500K
7.64M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
12/30/2024
Buy
$11.12
3,200
$36K
5.54M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
12/31/2024
Buy
$11.36
2,400
$27K
5.54M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
01/03/2025
Buy
$12.95
3,400
$44K
5.55M
NASDAQ GLSI Greenwich LifeSciences
Patel Snehal / director, 10 percent owner, officer: CEO and CFO
01/02/2025
Buy
$11.97
2,000
$24K
5.54M
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
01/03/2025
Sell
$11.03
1,167
$13K
2.92M
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
01/02/2025
Sell
$12.40
2,000
$25K
2.92M
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
12/31/2024
Sell
$12.30
2,000
$25K
2.92M
NASDAQ GYRE Gyre Therapeutics
Ma Songjiang / director, officer: President
12/30/2024
Sell
$12.50
2,000
$25K
2.92M
OTCMKTS HRGN Harvard Apparatus Regenerative Technology
He Junli / director, officer: CEO
12/24/2024
Buy
$2.87
2,299
$7K
262,000
NASDAQ HCAT Health Catalyst
Gallagher Duncan / director
12/30/2024
Sell
$6.93
4,500
$31K
69,938
NYSE HUM Humana
Huval Timothy S. / officer: Chief Administrative Officer
12/31/2024
Sell
$256.26
3,703
$949K
8,181
NASDAQ ICUI ICU Medical
Jain Vivek / director, officer: Chairman and CEO
01/02/2025
Sell
$155.48
1,373
$213K
104,593
NASDAQ INSM Insmed
Lewis William / director, officer: Chair and CEO
01/02/2025
Sell
$69.86
6,830
$477K
233,924
NASDAQ INSM Insmed
Lewis William / director, officer: Chair and CEO
01/02/2025
Sell
$69.84
18,750
$1.310M
384,960
NASDAQ NTLA Intellia Therapeutics
Clark Eliana / officer: EVP, Chief Technical Officer
01/03/2025
Sell
$12.18
7,422
$90K
64,048
NASDAQ NTLA Intellia Therapeutics
Clark Eliana / officer: EVP, Chief Technical Officer
01/02/2025
Sell
$12.03
556
$7K
71,470
NASDAQ IVVD Invivyd
MCGUIRE TERRANCE / director
12/31/2024
Sell
$0.45
103,474
$46K
3.07M
NASDAQ IVVD Invivyd
MCGUIRE TERRANCE / director
12/30/2024
Sell
$0.48
86,545
$42K
3.17M
NASDAQ IVVD Invivyd
MCGUIRE TERRANCE / director
12/27/2024
Sell
$0.52
83,744
$44K
3.26M
NYSE MCK McKesson
Smith LeAnn B / officer: EVP & Chief HR Officer
01/02/2025
Sell
$572.79
579
$332K
864
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$158.74
641
$102K
45,641
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$158.73
480
$76K
45,802
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$160.70
288
$46K
44,782
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$160.67
570
$92K
254,372
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$160.68
304
$49K
44,782
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$159.65
900
$144K
254,942
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$158.71
1,230
$195K
255,842
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$159.76
732
$117K
45,070
NASDAQ NTRA Natera
Sheena Jonathan / director, other: CO-FOUNDER
01/02/2025
Sell
$159.69
555
$89K
45,086
NASDAQ NBIX Neurocrine Biosciences
Delaet Ingrid / officer: Chief Regulatory Officer
12/31/2024
Sell
$138.10
272
$38K
2,507
NASDAQ NAMS NewAmsterdam Pharma
ForGrowth NAP B.V. / 10 percent owner
12/30/2024
Sell
$25.54
29,846
$762K
10.66M
NASDAQ NVAX Novavax
YOUNG JAMES F / director
12/24/2024
Sell
$8.48
4,600
$39K
57,160
NASDAQ NVAX Novavax
King Rachel K. / director
12/13/2024
Sell
$9.02
4,150
$37K
14,770
NASDAQ NVAX Novavax
YOUNG JAMES F / director
12/31/2024
Sell
$8.00
5,400
$43K
51,760
NASDAQ NRIX Nurix Therapeutics
Ring Christine / officer: Chief Legal Officer
01/02/2025
Sell
$19.50
5,760
$112K
28,084
NASDAQ PASG Pasge Bio
Lynx1 Capital Management LP / 10 percent owner
12/27/2024
Buy
$0.65
373,645
$241K
9.26M
NYSE PEN Penumbra
Grewal Harpreet / director
01/03/2025
Sell
$241.28
167
$40K
8,530
NYSE PEN Penumbra
Kassing Don W. / director
01/02/2025
Sell
$238.84
170
$41K
665
NASDAQ DTIL Precision BioSciences
Germano Geno J / director
12/30/2024
Buy
$4.49
3,605
$16K
7,807
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
12/31/2024
Buy
$1.21
5,000
$6K
142,553
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
12/30/2024
Buy
$1.20
10,000
$12K
137,553
NASDAQ PBYI Puma Biotechnology
AUERBACH ALAN H / director, 10 percent owner, officer: President and CEO
01/02/2025
Sell
$3.15
33,841
$107K
7.03M
NASDAQ PBYI Puma Biotechnology
HUNT DOUGLAS M / officer: See Remarks
01/02/2025
Sell
$3.15
8,633
$27K
124,594
NASDAQ PBYI Puma Biotechnology
Ludwig Jeffrey Jerome / officer: Chief Commercial Officer
01/02/2025
Sell
$3.15
9,437
$30K
108,951
NASDAQ PBYI Puma Biotechnology
NOUGUES MAXIMO F / officer: Chief Financial Officer
01/02/2025
Sell
$3.15
10,227
$32K
152,295
NASDAQ QSI Quantum-Si
ROTHBERG JONATHAN M / director, 10 percent owner:
12/27/2024
Sell
$3.30
834,254
$2.756M
1.29M
NASDAQ QSI Quantum-Si
ROTHBERG JONATHAN M / director, 10 percent owner:
12/27/2024
Sell
$4.10
42,313
$173K
1.25M
NASDAQ RLAY Relay Therapeutics
Rahmer Peter / officer: See remarks
01/06/2025
Sell
$4.45
16,576
$74K
308,754
NASDAQ RLAY Relay Therapeutics
Adams Brian / officer: Chief Legal Officer
12/27/2024
Sell
$4.38
299
$1K
321,608
NASDAQ RLAY Relay Therapeutics
Rahmer Peter / officer: See remarks
01/03/2025
Sell
$4.30
32,177
$138K
325,330
NASDAQ RLAY Relay Therapeutics
Rahmer Peter / officer: See remarks
01/02/2025
Sell
$4.15
32,156
$133K
357,507
NYSEAMEX RVP Retractable Technologies
SHAW THOMAS J / director, 10 percent owner, officer: PRESIDENT AND CEO
12/31/2024
Buy
$0.68
443
$300
14.92M
NASDAQ ROIV Roivant
Venker Eric / officer: President & COO
12/27/2024
Sell
$11.82
176,900
$2.091M
668,680
NASDAQ ROIV Roivant
Venker Eric / officer: President & COO
12/30/2024
Sell
$11.54
177,704
$2.051M
740,976
NASDAQ SGHT Sight Sciences
Bauerlein Alison / officer: Chief Financial Officer
01/03/2025
Sell
$3.52
10,102
$36K
382,453
NASDAQ SGHT Sight Sciences
HAYDEN JEREMY B. / officer: Chief Legal Officer
01/03/2025
Sell
$3.52
4,864
$17K
153,823
NASDAQ SGHT Sight Sciences
Badawi David / director, officer: Chief Technology Officer
01/03/2025
Sell
$3.52
3,111
$11K
1.75M
NASDAQ SGHT Sight Sciences
Badawi Paul / director, officer: President and CEO
01/02/2025
Sell
$3.60
12,236
$44K
5.71M
NASDAQ SLNO Soleno Therapeutics
Mackaness James H / officer: CHIEF FINANCIAL OFFICER
01/02/2025
Sell
$45.37
3,762
$171K
115,410
NASDAQ SLNO Soleno Therapeutics
Hirano Patricia C / officer: SEE REMARKS
01/03/2025
Sell
$46.18
1,459
$67K
105,902
NASDAQ SLNO Soleno Therapeutics
Yen Kristen / officer: SEE REMARKS
01/03/2025
Sell
$46.18
2,340
$108K
76,605
NASDAQ SLNO Soleno Therapeutics
Hirano Patricia C / officer: SEE REMARKS
01/02/2025
Sell
$45.92
124
$6K
107,361
NASDAQ SLNO Soleno Therapeutics
Yen Kristen / officer: SEE REMARKS
01/02/2025
Sell
$45.92
198
$9K
78,945
NASDAQ SLNO Soleno Therapeutics
Hirano Patricia C / officer: SEE REMARKS
01/02/2025
Sell
$45.37
1,447
$66K
107,485
NASDAQ SLNO Soleno Therapeutics
Anish Bhatnagar / director, officer: CHIEF EXECUTIVE OFFICER
01/03/2025
Sell
$46.18
10,154
$469K
698,462
NASDAQ SLNO Soleno Therapeutics
Yen Kristen / officer: SEE REMARKS
01/02/2025
Sell
$45.37
2,322
$105K
79,143
NASDAQ SLNO Soleno Therapeutics
Mackaness James H / officer: CHIEF FINANCIAL OFFICER
01/03/2025
Sell
$46.18
3,791
$175K
111,298
NASDAQ SLNO Soleno Therapeutics
Anish Bhatnagar / director, officer: CHIEF EXECUTIVE OFFICER
01/02/2025
Sell
$45.92
860
$39K
708,616
NASDAQ SLNO Soleno Therapeutics
Mackaness James H / officer: CHIEF FINANCIAL OFFICER
01/02/2025
Sell
$45.92
321
$15K
115,089
NASDAQ SLNO Soleno Therapeutics
Anish Bhatnagar / director, officer: CHIEF EXECUTIVE OFFICER
01/02/2025
Sell
$45.37
10,077
$457K
709,476
NASDAQ SRZN Surrozen
Williams Charles O / officer: CFO and COO
01/03/2025
Sell
$17.37
1,181
$21K
8,982
NASDAQ SRZN Surrozen
Li Yang / officer: Exec. Vice President, Research
01/03/2025
Sell
$17.37
843
$15K
13,345
NASDAQ TERN Terns Pharmaceuticals
Vignola Mark J. / officer: Chief Financial Officer
01/06/2025
Sell
$5.80
9,059
$53K
74,752
NASDAQ TERN Terns Pharmaceuticals
Quigley Jill M. / director
01/06/2025
Sell
$5.79
8,760
$51K
0
NASDAQ TERN Terns Pharmaceuticals
Vignola Mark J. / officer: Chief Financial Officer
01/02/2025
Sell
$5.72
8,129
$47K
83,811
NASDAQ TERN Terns Pharmaceuticals
Quigley Jill M. / director
01/02/2025
Sell
$5.72
6,240
$36K
8,760
NASDAQ TERN Terns Pharmaceuticals
Kuriakose Emil / officer: Chief Medical Officer
01/02/2025
Sell
$5.71
4,481
$26K
54,269
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/30/2024
Sell
$355.69
500
$178K
2,000
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/30/2024
Sell
$356.38
3,025
$1.078M
3,157
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/30/2024
Sell
$358.17
100
$36K
0
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/30/2024
Sell
$358.18
400
$143K
0
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/30/2024
Sell
$355.46
1,318
$468K
6,182
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/30/2024
Sell
$357.37
1,080
$386K
100
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/30/2024
Sell
$357.28
2,757
$985K
400
NASDAQ UTHR United Therapeutics
BENKOWITZ MICHAEL / officer: PRESIDENT AND COO
12/30/2024
Sell
$356.51
820
$292K
1,180
NASDAQ UTHR United Therapeutics
Mesa Nilda / director
12/30/2024
Sell
$355.77
255
$91K
5,528
NASDAQ PCVX Vaxcyte
Wassil Jim / officer: CHIEF OPERATING OFFICER
01/02/2025
Sell
$84.43
1,161
$98K
205,695
NASDAQ PCVX Vaxcyte
Wassil Jim / officer: CHIEF OPERATING OFFICER
01/02/2025
Sell
$83.69
5,483
$459K
206,856
NASDAQ PCVX Vaxcyte
Wassil Jim / officer: CHIEF OPERATING OFFICER
01/02/2025
Sell
$82.88
1,356
$112K
212,339
NASDAQ VKTX Viking Therapeutics
Lian Brian / director, officer: President & CEO
01/06/2025
Sell
$43.32
19,000
$823K
2.37M
NASDAQ VKTX Viking Therapeutics
Lian Brian / director, officer: President & CEO
01/06/2025
Sell
$42.68
175,490
$7.491M
2.39M
NASDAQ VKTX Viking Therapeutics
ZANTE GREG / officer: Chief Financial Officer
01/06/2025
Sell
$43.32
4,700
$204K
165,259
NASDAQ VKTX Viking Therapeutics
ZANTE GREG / officer: Chief Financial Officer
01/06/2025
Sell
$42.69
45,609
$1.947M
169,959
NASDAQ VKTX Viking Therapeutics
Mancini Marianna / officer: Chief Operating Officer
01/06/2025
Sell
$43.32
5,100
$221K
374,134
NASDAQ VKTX Viking Therapeutics
Mancini Marianna / officer: Chief Operating Officer
01/06/2025
Sell
$42.69
49,115
$2.097M
379,234
NASDAQ VOR Vor Bio
Reprogrammed Interchange LLC / 10 percent owner
12/30/2024
Buy
$0.99
38.97M
$38.750M
38.97M
NASDAQ VOR Vor Bio
Attar Eyal C. / officer: CHIEF MEDICAL OFFICER
12/27/2024
Sell
$1.25
10,334
$13K
81,439
NASDAQ VOR Vor Bio
Reprogrammed Interchange LLC / 10 percent owner
12/30/2024
Buy
$0.84
48.72M
$40.825M
48.72M
NASDAQ XLO Xilio Therapeutics
Brennan Kevin M. / officer: SVP, FINANCE AND ACCOUNTING
01/02/2025
Sell
$0.98
1,803
$2K
3,197
NASDAQ XLO Xilio Therapeutics
Frankenfield Christopher James / officer: Chief Financial Officer
01/02/2025
Sell
$0.98
6,954
$7K
12,421
NASDAQ ZLAB Zai Lab
Amado Rafael / officer: See Remarks
12/31/2024
Sell
$26.28
7,583
$199K
33,834
NASDAQ ZYME Zymeworks
EcoR1 Capital, LLC / director, 10 percent owner:
12/31/2024
Buy
$14.57
146,501
$2.134M
15.03M
NASDAQ ZYME Zymeworks
EcoR1 Capital, LLC / director, 10 percent owner:
01/02/2025
Buy
$14.78
157,880
$2.333M
15.19M
NASDAQ ZYME Zymeworks
Smith Jeffrey T L / officer: EVP & Chief Medical Officer
01/06/2025
Sell
$14.92
11,110
$166K
8,890
NASDAQ ZYME Zymeworks
Moore Paul Andrew / officer: Chief Scientific Officer
01/06/2025
Sell
$14.92
9,792
$146K
14,741
NASDAQ ZYME Zymeworks
Galbraith Kenneth / director, officer: Chair & CEO
01/06/2025
Sell
$14.92
23,885
$356K
47,543
NASDAQ ZYME Zymeworks
Moore Paul Andrew / officer: Chief Scientific Officer
01/06/2025
Sell
$14.92
11,408
$170K
23,333
NASDAQ ZYME Zymeworks
Galbraith Kenneth / director, officer: Chair & CEO
01/06/2025
Sell
$14.92
33,406
$499K
80,803
NASDAQ ZYME Zymeworks
EcoR1 Capital, LLC / director, 10 percent owner:
12/30/2024
Buy
$14.47
58,988
$853K
14.88M
NASDAQ ZYXI Zynex
MOORHEAD DANIEL J / officer: CHIEF FINANCIAL OFFICER
01/02/2025
Sell
$7.88
10,000
$79K
26,299

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous